Two different creatine transporters are found in different parts of the body— one is mostly in the kidney and eye, the other in the brain, heart, and muscles— which probably means they do different...

From: The cataract and glucosuria associated monocarboxylate transporter MCT12 is a new creatine transporter.

Strongly supported

Multiple high-quality studies back this claim.

6
Pro
0
Against
descriptive
1 study

Not medical advice. For informational purposes only. Always consult a healthcare professional.

What this claim means

Two different creatine transporters are found in different parts of the body— one is mostly in the kidney and eye, the other in the brain, heart, and muscles— which probably means they do different...

See the technical phrasing

SLC16A12 (MCT12) is predominantly expressed in the human kidney and retina, whereas SLC6A8 (CRT1) is primarily expressed in the brain, heart, and skeletal muscle, indicating distinct tissue-specific expression patterns that suggest specialized physiological roles for these two creatine transporters.

What the research says

Supports

1 study

6

Study: The cataract and glucosuria associated monocarboxylate transporter MCT12 is a new creatine transporter.

This study provides evidence supporting the claim.

Contradicts

0 studies

0

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.